Target intelligence / Profile preview

MicroRNA 548f-2 (MIR548F2)

Target
MIR548F2
Molecular classification
MicroRNA, Non-coding RNA, Regulatory RNA
01

Overview

MicroRNA 548f-2 (MIR548F2) is a small non-coding RNA molecule (miRNA) that plays a role in the post-transcriptional regulation of gene expression in multicellular organisms[1]. It is transcribed from its gene locus as a precursor that undergoes enzymatic processing (by Drosha and Dicer) to yield a mature miRNA, which is incorporated into the RISC complex. The mature miRNA regulates cellular pathways by binding to complementary sequences in target mRNAs, leading to translational repression or mRNA degradation[1]. Emerging evidence implicates the miR-548F family (including miR-548F-2 and closely related members) in cancer biology, particularly in processes such as cell cycle control, proliferation, and cytoskeletal organization, with strong evidence in triple-negative breast cancer. However, direct evidence on MIR548F2-specific mechanisms and disease associations remains limited; most functional and disease associations are extrapolated from family members and broader miRNA research[2].

Other names
hsa-mir-548f-2MIRN548F2MIR548F-2MIR548F2
02

Mechanism of action

MicroRNA-mediated gene silencing; RNA-induced silencing complex (RISC) targeting of mRNAs for degradation or translational repression[1]

03

Biological functions

Post-transcriptional regulation of gene expressionRegulation of mRNA stabilityTranslational inhibitionPossible roles in cell cycle, cell proliferation, and cell adhesion (based on related miR-548F-3p data)[2]
04

Disease associations

Cancer (notably breast cancer, especially triple-negative breast cancer, via the related miR-548F family)[2]Potentially other diseases based on general microRNA dysregulation
05

Safety considerations

Therapeutic delivery and off-target gene regulation are general concerns for microRNA-based therapeutics[2]
06

Biomarkers

Potential biomarker for triple-negative breast cancer and other cancer phenotypes, pending further validation[2]

Beyond the preview

Go deeper on MicroRNA 548f-2 (MIR548F2).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on MicroRNA 548f-2 (MIR548F2).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call